For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220414:nRSN4358Ia&default-theme=true
RNS Number : 4358I Tristel PLC 14 April 2022
Tristel plc
("Tristel", the "Company" or the "Group")
Exercise of Share Options and Total Voting Rights
Tristel plc (AIM: TSTL), the manufacturer of infection prevention products
utilising proprietary chlorine dioxide technology announces that it has issued
and allotted a total of 29,950 new ordinary shares of 1 penny each in the
capital of the Company ("Ordinary Shares") following the exercise of options
by employees of the Group.
Application has been made to the London Stock Exchange for the 29,950 new
Ordinary Shares to be admitted to trading on AIM ("Admission") and it is
expected that Admission will become effective and trading will commence at
8.00 a.m. on 22 April 2022.
After Admission, the total number of Ordinary Shares in issue will be
47,224,993 and the total number of voting rights will therefore be 47,224,993.
This figure may be used by shareholders as the denominator for the
calculations by which they will determine if they are required to notify their
interest in, or a change to their interest in, the share capital of the
Company under the FCA's Disclosure Guidance and Transparency Rules.
Tristel plc www.tristel.com
Paul Swinney, Chief Executive Tel: 01638 721 500
Liz Dixon, Finance Director
finnCap Limited - Nominated Adviser and Broker
Geoff Nash / Charles Beeson, Corporate Finance Tel: 020 7220 0500
Alice Lane, Corporate Broking
Walbrook PR Ltd tristel@walbrookpr.com
Tel: 020 7933
8780
Paul McManus Mob: 07980 541 893
Lianne Cawthorne Mob: 07584 391 303
This announcement contains inside information for the purposes of Article 7 of
the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law
by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is
disclosed in accordance with the company's obligations under Article 17 of
MAR.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END IOEBGGDSGSBDGDS